The ultimate goal of a personalized approach to prostate cancer patient management relies on two prerequisites: the development of preclinical but clinically relevant model systems and robust prognostic and predictive biomarkers.
The past several years have shown significant progress towards these two prerequisites which will be highlighted in this review using some notable examples.
Written by:
Korzeniewski N, Tapia-Laliena M, Tolstov Y, Pahernik S, Hadaschik B, Hohenfellner M, Duensing S. Are you the author?
Sektion Molekulare Uroonkologie, Urologische Universitätsklinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 517, 69120, Heidelberg, Deutschland.
Reference: Urologe A. 2013 Sep;52(9):1256-60.
doi: 10.1007/s00120-013-3310-6
PubMed Abstract
PMID: 23942741
Article in German.
UroToday.com Prostate Cancer Section
